Global Enoxaparin Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery
- MAI4645313
- 129 Pages
- September 2021
- Pharmaceuticals
Based on the Enoxaparin market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed in detail. To Boost Growth during the epidemic era, this report analyzes in detail for the potential risks and opportunities which can be focused on.
In Chapter 2.4 of the report, we share our perspectives for the impact of COVID-19 from the long and short term.
In chapter 3.4, we provide the influence of the crisis on the industry chain, especially for marketing channels.
In chapters 8-13, we update the timely industry economic revitalization plan of the country-wise government.
Key players in the global Enoxaparin market covered in Chapter 5:
Boehringer Ingelheim
Eisai Inc.
Pfizer, Inc.
Bristol-Myers Squibb Company
Abbott India Limited
GlaxoSmithKline Plc.
Aspen Holdings
Sanofi S.A.
Teva Pharmaceutical Industries Ltd.
Bayer Healthcare AG
In Chapter 6, on the basis of types, the Enoxaparin market from 2015 to 2025 is primarily split into:
0.4ml
0.6ml
In Chapter 7, on the basis of applications, the Enoxaparin market from 2015 to 2025 covers:
Hospital
Research Use
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 8-13:
North America (Covered in Chapter 9)
United States
Canada
Mexico
Europe (Covered in Chapter 10)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 11)
China
Japan
South Korea
Australia
India
South America (Covered in Chapter 12)
Brazil
Argentina
Columbia
Middle East and Africa (Covered in Chapter 13)
UAE
Egypt
South Africa
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
1 Market Overview
1.1 Product Definition and Market Characteristics
1.2 Global Enoxaparin Market Size
1.3 Market Segmentation
1.4 Global Macroeconomic Analysis
1.5 SWOT Analysis
2. Market Dynamics
2.1 Market Drivers
2.2 Market Constraints and Challenges
2.3 Emerging Market Trends
2.4 Impact of COVID-19
2.4.1 Short-term Impact
2.4.2 Long-term Impact
3 Associated Industry Assessment
3.1 Supply Chain Analysis
3.2 Industry Active Participants
3.2.1 Suppliers of Raw Materials
3.2.2 Key Distributors/Retailers
3.3 Alternative Analysis
3.4 The Impact of Covid-19 From the Perspective of Industry Chain
4 Market Competitive Landscape
4.1 Industry Leading Players
4.2 Industry News
4.2.1 Key Product Launch News
4.2.2 M&A and Expansion Plans
5 Analysis of Leading Companies
5.1 Boehringer Ingelheim
5.1.1 Boehringer Ingelheim Company Profile
5.1.2 Boehringer Ingelheim Business Overview
5.1.3 Boehringer Ingelheim Enoxaparin Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.1.4 Boehringer Ingelheim Enoxaparin Products Introduction
5.2 Eisai Inc.
5.2.1 Eisai Inc. Company Profile
5.2.2 Eisai Inc. Business Overview
5.2.3 Eisai Inc. Enoxaparin Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.2.4 Eisai Inc. Enoxaparin Products Introduction
5.3 Pfizer, Inc.
5.3.1 Pfizer, Inc. Company Profile
5.3.2 Pfizer, Inc. Business Overview
5.3.3 Pfizer, Inc. Enoxaparin Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.3.4 Pfizer, Inc. Enoxaparin Products Introduction
5.4 Bristol-Myers Squibb Company
5.4.1 Bristol-Myers Squibb Company Company Profile
5.4.2 Bristol-Myers Squibb Company Business Overview
5.4.3 Bristol-Myers Squibb Company Enoxaparin Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.4.4 Bristol-Myers Squibb Company Enoxaparin Products Introduction
5.5 Abbott India Limited
5.5.1 Abbott India Limited Company Profile
5.5.2 Abbott India Limited Business Overview
5.5.3 Abbott India Limited Enoxaparin Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.5.4 Abbott India Limited Enoxaparin Products Introduction
5.6 GlaxoSmithKline Plc.
5.6.1 GlaxoSmithKline Plc. Company Profile
5.6.2 GlaxoSmithKline Plc. Business Overview
5.6.3 GlaxoSmithKline Plc. Enoxaparin Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.6.4 GlaxoSmithKline Plc. Enoxaparin Products Introduction
5.7 Aspen Holdings
5.7.1 Aspen Holdings Company Profile
5.7.2 Aspen Holdings Business Overview
5.7.3 Aspen Holdings Enoxaparin Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.7.4 Aspen Holdings Enoxaparin Products Introduction
5.8 Sanofi S.A.
5.8.1 Sanofi S.A. Company Profile
5.8.2 Sanofi S.A. Business Overview
5.8.3 Sanofi S.A. Enoxaparin Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.8.4 Sanofi S.A. Enoxaparin Products Introduction
5.9 Teva Pharmaceutical Industries Ltd.
5.9.1 Teva Pharmaceutical Industries Ltd. Company Profile
5.9.2 Teva Pharmaceutical Industries Ltd. Business Overview
5.9.3 Teva Pharmaceutical Industries Ltd. Enoxaparin Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.9.4 Teva Pharmaceutical Industries Ltd. Enoxaparin Products Introduction
5.10 Bayer Healthcare AG
5.10.1 Bayer Healthcare AG Company Profile
5.10.2 Bayer Healthcare AG Business Overview
5.10.3 Bayer Healthcare AG Enoxaparin Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.10.4 Bayer Healthcare AG Enoxaparin Products Introduction
6 Market Analysis and Forecast, By Product Types
6.1 Global Enoxaparin Sales, Revenue and Market Share by Types (2015-2020)
6.1.1 Global Enoxaparin Sales and Market Share by Types (2015-2020)
6.1.2 Global Enoxaparin Revenue and Market Share by Types (2015-2020)
6.1.3 Global Enoxaparin Price by Types (2015-2020)
6.2 Global Enoxaparin Market Forecast by Types (2020-2025)
6.2.1 Global Enoxaparin Market Forecast Sales and Market Share by Types (2020-2025)
6.2.2 Global Enoxaparin Market Forecast Revenue and Market Share by Types (2020-2025)
6.3 Global Enoxaparin Sales, Price and Growth Rate by Types (2015-2020)
6.3.1 Global Enoxaparin Sales, Price and Growth Rate of 0.4ml
6.3.2 Global Enoxaparin Sales, Price and Growth Rate of 0.6ml
6.4 Global Enoxaparin Market Revenue and Sales Forecast, by Types (2020-2025)
6.4.1 0.4ml Market Revenue and Sales Forecast (2020-2025)
6.4.2 0.6ml Market Revenue and Sales Forecast (2020-2025)
7 Market Analysis and Forecast, By Applications
7.1 Global Enoxaparin Sales, Revenue and Market Share by Applications (2015-2020)
7.1.1 Global Enoxaparin Sales and Market Share by Applications (2015-2020)
7.1.2 Global Enoxaparin Revenue and Market Share by Applications (2015-2020)
7.2 Global Enoxaparin Market Forecast by Applications (2020-2025)
7.2.1 Global Enoxaparin Market Forecast Sales and Market Share by Applications (2020-2025)
7.2.2 Global Enoxaparin Market Forecast Revenue and Market Share by Applications (2020-2025)
7.3 Global Revenue, Sales and Growth Rate by Applications (2015-2020)
7.3.1 Global Enoxaparin Revenue, Sales and Growth Rate of Hospital (2015-2020)
7.3.2 Global Enoxaparin Revenue, Sales and Growth Rate of Research Use (2015-2020)
7.4 Global Enoxaparin Market Revenue and Sales Forecast, by Applications (2020-2025)
7.4.1 Hospital Market Revenue and Sales Forecast (2020-2025)
7.4.2 Research Use Market Revenue and Sales Forecast (2020-2025)
8 Market Analysis and Forecast, By Regions
8.1 Global Enoxaparin Sales by Regions (2015-2020)
8.2 Global Enoxaparin Market Revenue by Regions (2015-2020)
8.3 Global Enoxaparin Market Forecast by Regions (2020-2025)
9 North America Enoxaparin Market Analysis
9.1 Market Overview and Prospect Analysis
9.2 North America Enoxaparin Market Sales and Growth Rate (2015-2020)
9.3 North America Enoxaparin Market Revenue and Growth Rate (2015-2020)
9.4 North America Enoxaparin Market Forecast
9.5 The Influence of COVID-19 on North America Market
9.6 North America Enoxaparin Market Analysis by Country
9.6.1 U.S. Enoxaparin Sales and Growth Rate
9.6.2 Canada Enoxaparin Sales and Growth Rate
9.6.3 Mexico Enoxaparin Sales and Growth Rate
10 Europe Enoxaparin Market Analysis
10.1 Market Overview and Prospect Analysis
10.2 Europe Enoxaparin Market Sales and Growth Rate (2015-2020)
10.3 Europe Enoxaparin Market Revenue and Growth Rate (2015-2020)
10.4 Europe Enoxaparin Market Forecast
10.5 The Influence of COVID-19 on Europe Market
10.6 Europe Enoxaparin Market Analysis by Country
10.6.1 Germany Enoxaparin Sales and Growth Rate
10.6.2 United Kingdom Enoxaparin Sales and Growth Rate
10.6.3 France Enoxaparin Sales and Growth Rate
10.6.4 Italy Enoxaparin Sales and Growth Rate
10.6.5 Spain Enoxaparin Sales and Growth Rate
10.6.6 Russia Enoxaparin Sales and Growth Rate
11 Asia-Pacific Enoxaparin Market Analysis
11.1 Market Overview and Prospect Analysis
11.2 Asia-Pacific Enoxaparin Market Sales and Growth Rate (2015-2020)
11.3 Asia-Pacific Enoxaparin Market Revenue and Growth Rate (2015-2020)
11.4 Asia-Pacific Enoxaparin Market Forecast
11.5 The Influence of COVID-19 on Asia Pacific Market
11.6 Asia-Pacific Enoxaparin Market Analysis by Country
11.6.1 China Enoxaparin Sales and Growth Rate
11.6.2 Japan Enoxaparin Sales and Growth Rate
11.6.3 South Korea Enoxaparin Sales and Growth Rate
11.6.4 Australia Enoxaparin Sales and Growth Rate
11.6.5 India Enoxaparin Sales and Growth Rate
12 South America Enoxaparin Market Analysis
12.1 Market Overview and Prospect Analysis
12.2 South America Enoxaparin Market Sales and Growth Rate (2015-2020)
12.3 South America Enoxaparin Market Revenue and Growth Rate (2015-2020)
12.4 South America Enoxaparin Market Forecast
12.5 The Influence of COVID-19 on South America Market
12.6 South America Enoxaparin Market Analysis by Country
12.6.1 Brazil Enoxaparin Sales and Growth Rate
12.6.2 Argentina Enoxaparin Sales and Growth Rate
12.6.3 Columbia Enoxaparin Sales and Growth Rate
13 Middle East and Africa Enoxaparin Market Analysis
13.1 Market Overview and Prospect Analysis
13.2 Middle East and Africa Enoxaparin Market Sales and Growth Rate (2015-2020)
13.3 Middle East and Africa Enoxaparin Market Revenue and Growth Rate (2015-2020)
13.4 Middle East and Africa Enoxaparin Market Forecast
13.5 The Influence of COVID-19 on Middle East and Africa Market
13.6 Middle East and Africa Enoxaparin Market Analysis by Country
13.6.1 UAE Enoxaparin Sales and Growth Rate
13.6.2 Egypt Enoxaparin Sales and Growth Rate
13.6.3 South Africa Enoxaparin Sales and Growth Rate
14 Conclusions and Recommendations
14.1 Key Market Findings and Prospects
14.2 Advice for Investors
15 Appendix
15.1 Methodology
15.2 Research Data Source
List of Tables and Figures
Figure Product Picture
Figure Global Enoxaparin Market Size and Growth Rate 2015-2025
Table Enoxaparin Key Market Segments
Figure Global Enoxaparin Market Revenue ($) Segment by Type from 2015-2020
Figure Global Enoxaparin Market Revenue ($) Segment by Applications from 2015-2020
Table SWOT Analysis
Figure Global COVID-19 Status
Figure Supply Chain
Table Major Players Headquarters, and Service Area of Enoxaparin
Table Major Players Revenue in 2019
Figure Major Players Revenue Share in 2019
Table Boehringer Ingelheim Company Profile
Table Boehringer Ingelheim Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Boehringer Ingelheim Production and Growth Rate
Figure Boehringer Ingelheim Market Revenue ($) Market Share 2015-2020
Table Eisai Inc. Company Profile
Table Eisai Inc. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Eisai Inc. Production and Growth Rate
Figure Eisai Inc. Market Revenue ($) Market Share 2015-2020
Table Pfizer, Inc. Company Profile
Table Pfizer, Inc. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Pfizer, Inc. Production and Growth Rate
Figure Pfizer, Inc. Market Revenue ($) Market Share 2015-2020
Table Bristol-Myers Squibb Company Company Profile
Table Bristol-Myers Squibb Company Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Bristol-Myers Squibb Company Production and Growth Rate
Figure Bristol-Myers Squibb Company Market Revenue ($) Market Share 2015-2020
Table Abbott India Limited Company Profile
Table Abbott India Limited Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Abbott India Limited Production and Growth Rate
Figure Abbott India Limited Market Revenue ($) Market Share 2015-2020
Table GlaxoSmithKline Plc. Company Profile
Table GlaxoSmithKline Plc. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure GlaxoSmithKline Plc. Production and Growth Rate
Figure GlaxoSmithKline Plc. Market Revenue ($) Market Share 2015-2020
Table Aspen Holdings Company Profile
Table Aspen Holdings Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Aspen Holdings Production and Growth Rate
Figure Aspen Holdings Market Revenue ($) Market Share 2015-2020
Table Sanofi S.A. Company Profile
Table Sanofi S.A. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Sanofi S.A. Production and Growth Rate
Figure Sanofi S.A. Market Revenue ($) Market Share 2015-2020
Table Teva Pharmaceutical Industries Ltd. Company Profile
Table Teva Pharmaceutical Industries Ltd. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Teva Pharmaceutical Industries Ltd. Production and Growth Rate
Figure Teva Pharmaceutical Industries Ltd. Market Revenue ($) Market Share 2015-2020
Table Bayer Healthcare AG Company Profile
Table Bayer Healthcare AG Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Bayer Healthcare AG Production and Growth Rate
Figure Bayer Healthcare AG Market Revenue ($) Market Share 2015-2020
Table Global Enoxaparin Sales by Types (2015-2020)
Table Global Enoxaparin Sales Share by Types (2015-2020)
Table Global Enoxaparin Revenue ($) by Types (2015-2020)
Table Global Enoxaparin Revenue Share by Types (2015-2020)
Table Global Enoxaparin Price ($) by Types (2015-2020)
Table Global Enoxaparin Market Forecast Sales by Types (2020-2025)
Table Global Enoxaparin Market Forecast Sales Share by Types (2020-2025)
Table Global Enoxaparin Market Forecast Revenue ($) by Types (2020-2025)
Table Global Enoxaparin Market Forecast Revenue Share by Types (2020-2025)
Figure Global 0.4ml Sales and Growth Rate (2015-2020)
Figure Global 0.4ml Price (2015-2020)
Figure Global 0.6ml Sales and Growth Rate (2015-2020)
Figure Global 0.6ml Price (2015-2020)
Figure Global Enoxaparin Market Revenue ($) and Growth Rate Forecast of 0.4ml (2020-2025)
Figure Global Enoxaparin Sales and Growth Rate Forecast of 0.4ml (2020-2025)
Figure Global Enoxaparin Market Revenue ($) and Growth Rate Forecast of 0.6ml (2020-2025)
Figure Global Enoxaparin Sales and Growth Rate Forecast of 0.6ml (2020-2025)
Table Global Enoxaparin Sales by Applications (2015-2020)
Table Global Enoxaparin Sales Share by Applications (2015-2020)
Table Global Enoxaparin Revenue ($) by Applications (2015-2020)
Table Global Enoxaparin Revenue Share by Applications (2015-2020)
Table Global Enoxaparin Market Forecast Sales by Applications (2020-2025)
Table Global Enoxaparin Market Forecast Sales Share by Applications (2020-2025)
Table Global Enoxaparin Market Forecast Revenue ($) by Applications (2020-2025)
Table Global Enoxaparin Market Forecast Revenue Share by Applications (2020-2025)
Figure Global Hospital Sales and Growth Rate (2015-2020)
Figure Global Hospital Price (2015-2020)
Figure Global Research Use Sales and Growth Rate (2015-2020)
Figure Global Research Use Price (2015-2020)
Figure Global Enoxaparin Market Revenue ($) and Growth Rate Forecast of Hospital (2020-2025)
Figure Global Enoxaparin Sales and Growth Rate Forecast of Hospital (2020-2025)
Figure Global Enoxaparin Market Revenue ($) and Growth Rate Forecast of Research Use (2020-2025)
Figure Global Enoxaparin Sales and Growth Rate Forecast of Research Use (2020-2025)
Figure Global Enoxaparin Sales and Growth Rate (2015-2020)
Table Global Enoxaparin Sales by Regions (2015-2020)
Table Global Enoxaparin Sales Market Share by Regions (2015-2020)
Figure Global Enoxaparin Sales Market Share by Regions in 2019
Figure Global Enoxaparin Revenue and Growth Rate (2015-2020)
Table Global Enoxaparin Revenue by Regions (2015-2020)
Table Global Enoxaparin Revenue Market Share by Regions (2015-2020)
Figure Global Enoxaparin Revenue Market Share by Regions in 2019
Table Global Enoxaparin Market Forecast Sales by Regions (2020-2025)
Table Global Enoxaparin Market Forecast Sales Share by Regions (2020-2025)
Table Global Enoxaparin Market Forecast Revenue ($) by Regions (2020-2025)
Table Global Enoxaparin Market Forecast Revenue Share by Regions (2020-2025)
Figure North America Enoxaparin Market Sales and Growth Rate (2015-2020)
Figure North America Enoxaparin Market Revenue and Growth Rate (2015-2020)
Figure North America Enoxaparin Market Forecast Sales (2020-2025)
Figure North America Enoxaparin Market Forecast Revenue ($) (2020-2025)
Figure North America COVID-19 Status
Figure U.S. Enoxaparin Market Sales and Growth Rate (2015-2020)
Figure Canada Enoxaparin Market Sales and Growth Rate (2015-2020)
Figure Mexico Enoxaparin Market Sales and Growth Rate (2015-2020)
Figure Europe Enoxaparin Market Sales and Growth Rate (2015-2020)
Figure Europe Enoxaparin Market Revenue and Growth Rate (2015-2020)
Figure Europe Enoxaparin Market Forecast Sales (2020-2025)
Figure Europe Enoxaparin Market Forecast Revenue ($) (2020-2025)
Figure Europe COVID-19 Status
Figure Germany Enoxaparin Market Sales and Growth Rate (2015-2020)
Figure United Kingdom Enoxaparin Market Sales and Growth Rate (2015-2020)
Figure France Enoxaparin Market Sales and Growth Rate (2015-2020)
Figure Italy Enoxaparin Market Sales and Growth Rate (2015-2020)
Figure Spain Enoxaparin Market Sales and Growth Rate (2015-2020)
Figure Russia Enoxaparin Market Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Enoxaparin Market Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Enoxaparin Market Revenue and Growth Rate (2015-2020)
Figure Asia-Pacific Enoxaparin Market Forecast Sales (2020-2025)
Figure Asia-Pacific Enoxaparin Market Forecast Revenue ($) (2020-2025)
Figure Asia Pacific COVID-19 Status
Figure China Enoxaparin Market Sales and Growth Rate (2015-2020)
Figure Japan Enoxaparin Market Sales and Growth Rate (2015-2020)
Figure South Korea Enoxaparin Market Sales and Growth Rate (2015-2020)
Figure Australia Enoxaparin Market Sales and Growth Rate (2015-2020)
Figure India Enoxaparin Market Sales and Growth Rate (2015-2020)
Figure South America Enoxaparin Market Sales and Growth Rate (2015-2020)
Figure South America Enoxaparin Market Revenue and Growth Rate (2015-2020)
Figure South America Enoxaparin Market Forecast Sales (2020-2025)
Figure South America Enoxaparin Market Forecast Revenue ($) (2020-2025)
Figure Brazil Enoxaparin Market Sales and Growth Rate (2015-2020)
Figure Argentina Enoxaparin Market Sales and Growth Rate (2015-2020)
Figure Columbia Enoxaparin Market Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Enoxaparin Market Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Enoxaparin Market Revenue and Growth Rate (2015-2020)
Figure Middle East and Africa Enoxaparin Market Forecast Sales (2020-2025)
Figure Middle East and Africa Enoxaparin Market Forecast Revenue ($) (2020-2025)
Figure UAE Enoxaparin Market Sales and Growth Rate (2015-2020)
Figure Egypt Enoxaparin Market Sales and Growth Rate (2015-2020)
Figure South Africa Enoxaparin Market Sales and Growth Rate (2015-2020)
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
